why choose us

First received: April 13, 2023

Clinical Trial: Biomarker for Infection Risk in CLL and MM

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Myeloma

Study Type: OBSERVATIONAL


Official Title: Biomarker for Infection Risk in Chronic Lymphocytic Leukemia and Multiple Myeloma

Brief Summary: The aim of this research study is to use advanced immunology laboratory analysis to identify a more precise blood test that will predict infection risk in patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (CLL/SLL) or Multiple Myeloma (MM).

Read more